» Articles » PMID: 22544892

Effect of Mindfulness Training on Asthma Quality of Life and Lung Function: a Randomised Controlled Trial

Overview
Journal Thorax
Date 2012 May 1
PMID 22544892
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Background: This study evaluated the efficacy of a mindfulness training programme (mindfulness-based stress reduction (MBSR)) in improving asthma-related quality of life and lung function in patients with asthma.

Methods: A randomised controlled trial compared an 8-week MBSR group-based programme (n=42) with an educational control programme (n=41) in adults with mild, moderate or severe persistent asthma recruited at a university hospital outpatient primary care and pulmonary care clinic. Primary outcomes were quality of life (Asthma Quality of Life Questionnaire) and lung function (change from baseline in 2-week average morning peak expiratory flow (PEF)). Secondary outcomes were asthma control assessed by 2007 National Institutes of Health/National Heart Lung and Blood Institute guidelines, and stress (Perceived Stress Scale (PSS)). Follow-up assessments were conducted at 10 weeks, 6 and 12 months.

Results: At 12 months MBSR resulted in clinically significant improvements from baseline in quality of life (differential change in Asthma Quality of Life Questionnaire score for MBSR vs control: 0.66 (95% CI 0.30 to 1.03; p<0.001)) but not in lung function (morning PEF, PEF variability and forced expiratory volume in 1 s). MBSR also resulted in clinically significant improvements in perceived stress (differential change in PSS score for MBSR vs control: -4.5 (95% CI -7.1 to -1.9; p=0.001)). There was no significant difference (p=0.301) in percentage of patients in MBSR with well controlled asthma (7.3% at baseline to 19.4%) compared with the control condition (7.5% at baseline to 7.9%).

Conclusions: MBSR produced lasting and clinically significant improvements in asthma-related quality of life and stress in patients with persistent asthma, without improvements in lung function.

Clinical Trial Registration Number: Asthma and Mindfulness-Based Reduction (MBSR) Identifier: NCT00682669. clinicaltrials.gov.

Citing Articles

Clinically relevant effects of Mindfulness-Based Stress Reduction in individuals with asthma.

Higgins E, Davidson R, Busse W, Klaus D, Bednarek G, Goldman R Brain Behav Immun Health. 2022; 25:100509.

PMID: 36177306 PMC: 9513112. DOI: 10.1016/j.bbih.2022.100509.


Mindfulness-Based Stress Reduction for Coronary Artery Disease Patients: Potential Improvements in Mastery and Depressive Symptoms.

Lundgren O, Garvin P, Nilsson L, Tornerefelt V, Andersson G, Kristenson M J Clin Psychol Med Settings. 2021; 29(3):489-497.

PMID: 34585329 PMC: 9399009. DOI: 10.1007/s10880-021-09822-z.


A feasibility trial of a digital mindfulness-based intervention to improve asthma-related quality of life for primary care patients with asthma.

Ainsworth B, Stanescu S, Stuart B, Russell D, Liddiard M, Djukanovic R J Behav Med. 2021; 45(1):133-147.

PMID: 34448986 PMC: 8818629. DOI: 10.1007/s10865-021-00249-3.


Targeting excessive avoidance behavior to reduce anxiety related to asthma: A feasibility study of an exposure-based treatment delivered online.

Bonnert M, Sarnholm J, Andersson E, Bergstrom S, Lalouni M, Lundholm C Internet Interv. 2021; 25:100415.

PMID: 34401374 PMC: 8350602. DOI: 10.1016/j.invent.2021.100415.


Keeping weight off: Mindfulness-Based Stress Reduction alters amygdala functional connectivity during weight loss maintenance in a randomized control trial.

Chumachenko S, Cali R, Rosal M, Allison J, Person S, Ziedonis D PLoS One. 2021; 16(1):e0244847.

PMID: 33428638 PMC: 7799782. DOI: 10.1371/journal.pone.0244847.


References
1.
Markham A, Wilkinson J . Complementary and alternative medicines (CAM) in the management of asthma: an examination of the evidence. J Asthma. 2004; 41(2):131-9. DOI: 10.1081/jas-120028581. View

2.
Holgate S, Chuchalin A, Hebert J, Lotvall J, Persson G, Chung K . Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma. Clin Exp Allergy. 2004; 34(4):632-8. DOI: 10.1111/j.1365-2222.2004.1916.x. View

3.
Wisnivesky J, Lorenzo J, Feldman J, Leventhal H, Halm E . The relationship between perceived stress and morbidity among adult inner-city asthmatics. J Asthma. 2010; 47(1):100-4. DOI: 10.3109/02770900903426989. View

4.
Rietveld S . Symptom perception in asthma: a multidisciplinary review. J Asthma. 1998; 35(2):137-46. DOI: 10.3109/02770909809068201. View

5.
Boulet L, Bateman E, Voves R, Muller T, Wolf S, Engelstatter R . A randomized study comparing ciclesonide and fluticasone propionate in patients with moderate persistent asthma. Respir Med. 2007; 101(8):1677-86. DOI: 10.1016/j.rmed.2007.03.001. View